Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Whitehawk Therapeutics Inc (WHWK)

Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Whitehawk Therapeutics Inc 2 HEADQUARTERS PLAZA EAST BUILDING 11TH FLOOR MORRISTOWN NJ 7960 USA

https://ir.whitehawktx.com Employees: 40 P: 551-321-2234

Sector:

Medical

Description:

Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known as Aerpio Pharmaceuticals Inc., is based in LOS ANGELES.

Key Statistics

Overview:

Market Capitalization, $K 136,671
Enterprise Value, $K 108,001
Shares Outstanding, K 47,128
Float, K 23,611
% Float 50.10%
Short Interest, K 781
Short Float 1.66%
Days to Cover 6.21
Short Volume Ratio 0.30
% of Insider Shareholders 49.90%
% of Institutional Shareholders 52.08%

Financials:

Annual Sales, $ 25,980 K
Annual Net Income, $ -63,690 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -52,620 K
EBIT, $ -102,330 K
EBITDA, $ -103,440 K

Growth:

1-Year Return -6.55%
3-Year Return -76.94%
5-Year Return -91.10%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 71.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 11/06/25
Next Earnings Date 03/17/26
Earnings Per Share ttm -2.25
EPS Growth vs. Prev Qtr 65.79%
EPS Growth vs. Prev Year 43.48%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 08/27/21

WHWK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -68.32%
Return-on-Assets % -63.21%
Profit Margin % -245.15%
Debt/Equity 0.00
Price/Sales 9.80
Price/Cash Flow N/A
Price/Book 0.86
Book Value/Share 3.65
Interest Coverage -423.60
60-Month Beta 0.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar